PROS1 and COVID-19: Other studies also showed that plasma IgG from COVID-19 convalescents reacted with MERS-CoV S protein (20), and the mAbs targeting S2 subunit blocked MERS-CoV infection and showed cross-reactivity with betacoronaviruses (21).